What Analysts Say about the Xylem Inc. (XYL) Stock


Xylem Inc. (NYSE:XYL) saw a downside of -7.95% to close Monday at $101.42 after subtracting -$8.76 on the day. The 5-day average trading volume is 3,049,660 shares of the company’s common stock. It has gained $117.42 in the past week and touched a new high 1 time within the past 5 days. An average of 1,310,885 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,040,886.

XYL’s 1-month performance is -6.34% or -$8.31 on its low of $97.29 reached on 01/23/23. The company’s shares have touched a 52-week low of $72.08 and high of $118.58, with the stock’s rally to the 52-week high happening on 01/13/23. YTD, XYL has lost -8.28% or -$9.15 and has reached a new high 5 times. However, the current price is down -14.47% from the 52-week high price.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Insider Transactions

XYL stock investors last saw insider trading activity on Nov 04.Pine Matthew Francis (Senior Vice President) most recently sold 11,870 shares at $107.12 per share on Nov 04. This transaction cost the insider $1,271,537. Senior Vice President, Toussaint Claudia S, sold 16,825 shares at a price of $91.37 on Sep 06. Then, on Aug 10, Director Harker Victoria D sold 5,000 shares at a price of $100.26 per share. This transaction amounted to $501,287.

Valuation Metrics

XYL stock has a beta of 1.09. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 3.38 while the price-to-book (PB) in the most recent quarter is 5.68, with the price to cash flow ratio at 1638.30.

Xylem Inc.’s quick ratio for the period ended September 29 was 1.20, with the current ratio over the same period at 1.70. As well, the company’s long term debt to equity for the quarter ending September 29 was 0.58, while the total debt to equity was 0.73. In terms of profitability, the gross margin trailing 12 months is 37.50%. The firm’s gross profit as reported stood at $585.0 million against revenue of $5.2 billion.

Earnings Surprise

For the quarterly period ending September 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -850.0% to $12.0 million, while revenue of $112.0 million was -833.33% off the previous quarter. Analysts expected XYL to announce $0.66 per share in earnings in its latest quarter, but it posted $0.79, representing a 19.70% surprise. EBITDA for the quarter stood at more than $226.0 million. XYL stock balance sheet for the quarter ending September 29 shows that total liabilities totaled 4.88 billion, with total debt at $2.43 billion. Shareholders hold equity totaling $180.22 million.

Let’s look briefly at Xylem Inc. (XYL) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 23 January was 27.10% to suggest the stock is trending oversold, with historical volatility in this time period at 49.56%.

The stock’s 5-day moving average is $109.95, reflecting a -13.26% or -$15.51 change from its current price. XYL is currently trading -8.75% above its 20-day SMA, +10.18% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -6.33% and SMA200 by+16.72%.

Stochastic %K and %D was 21.08% and 34.96% and the average true range (ATR) pointed at 3.96. The RSI (14) points at 33.47%, while the 14-day stochastic is at 19.40% with the period’s ATR at 3.51. The stock’s 9-day MACD Oscillator is pointing at -5.56 and -4.87 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Xylem Inc. (NYSE: XYL), Raymond James downgraded it to an Underperform rating. They previously had a Mkt perform rating on the stock. Analysts offering their rating for XYL stock have a consensus rating for the stock as Hold. Currently, 1 brokerage advisors rate XYL as a “sell,”, while 11 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 4 have offered a “buy” rating.

What is XYL’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $92.00 and a high of $129.00, with their median price target at $115.00. Looking at these predictions, the average price target given by analysts is for Xylem Inc. (XYL) stock is $110.45.


Please enter your comment!
Please enter your name here